Treatment and outcomes of first troponin-negative nonST-segment elevation myocardial infarction

American Journal of Cardiology

Volumn 107, Issue 1, 2011, Pages 24-29

  Corteville, David C M ^a   Armstrong, David F ^b   Montgomery, Daniel G ^a   Kline Rogers, Eva ^a   Goldberger, Zachary D ^a   Froehlich, James B ^a   Gurm, Hitinder S ^a   Eagle, Kim A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Christiana Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; TROPONIN;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONGESTIVE HEART FAILURE; DEATH; FEMALE; HEART ARREST; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HOSPITAL CARE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOMES RESEARCH; PHARMACEUTICAL CARE; PRIORITY JOURNAL; STROKE;

AGED; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; TREATMENT OUTCOME; TROPONIN I;

EID: 78650094720     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.08.040     Document Type: Article

References (28)

1. T. Jernberg, and B. Lindahl A combination of troponin T and 12-lead electrocardiography: a valuable tool for early prediction of long-term mortality in patients with chest pain without ST-segment elevation Am Heart J 144 2002 804 810
2. T. Keller, T. Zeller, D. Peetz, S. Tzikas, A. Roth, E. Czyz, C. Bickel, S. Baldus, A. Warnholtz, M. Frohlich, C.R. Sinning, M.S. Eleftheriadis, P.S. Wild, R.B. Schnabel, E. Lubos, N. Jachmann, S. Genth-Zotz, F. Post, V. Nicaud, L. Tiret, K.J. Lackner, T.F. Munzel, and S. Blankenberg Sensitive troponin I assay in early diagnosis of acute myocardial infarction N Engl J Med 361 2009 868 877
3. C.A. Polanczyk, T.H. Lee, E.F. Cook, R. Walls, D. Wybenga, G. Printy-Klein, L. Ludwig, G. Guldbrandsen, and P.A. Johnson Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain J Am Coll Cardiol 32 1998 8 14
4. J.L. Januzzi Jr, L.K. Newby, S.A. Murphy, K. Pieper, E.M. Antman, D.A. Morrow, M.S. Sabatine, E.M. Ohman, C.P. Cannon, and E. Braunwald Predicting a late positive serum troponin in initially troponin-negative patients with nonST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies Am Heart J 151 2006 360 366
5. L.K. Newby, R.H. Christenson, E.M. Ohman, P.W. Armstrong, T.D. Thompson, K.L. Lee, C.W. Hamm, H.A. Katus, C. Cianciolo, C.B. Granger, E.J. Topol, and R.M. Califf Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes The GUSTO-IIa Investigators Circulation 98 1998 1853 1859
6. C.P. Cannon, W.S. Weintraub, L.A. Demopoulos, R. Vicari, M.J. Frey, N. Lakkis, F.J. Neumann, D.H. Robertson, P.T. DeLucca, P.M. DiBattiste, C.M. Gibson, and E. Braunwald Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887 (Pubitemid 32564900)
7. M. Chase, J.L. Robey, K.E. Zogby, K.L. Sease, F.S. Shofer, and J.E. Hollander Prospective validation of the Thrombolysis in Myocardial Infarction Risk Score in the emergency department chest pain population Ann Emerg Med 48 2006 252 259
8. R. Glaser, H.C. Herrmann, S.A. Murphy, L.A. Demopoulos, P.M. DiBattiste, C.P. Cannon, and E. Braunwald Benefit of an early invasive management strategy in women with acute coronary syndromes JAMA 288 2002 3124 3129
9. E.W. Tang, C.K. Wong, and P. Herbison Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome Am Heart J 153 2007 29 35
10. D.A. Morrow, C.P. Cannon, N. Rifai, M.J. Frey, R. Vicari, N. Lakkis, D.H. Robertson, D.A. Hille, P.T. DeLucca, P.M. DiBattiste, L.A. Demopoulos, W.S. Weintraub, and E. Braunwald Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and nonST elevation myocardial infarction: results from a randomized trial JAMA 286 2001 2405 2412
11. G.G. Schwartz, A.G. Olsson, M.D. Ezekowitz, P. Ganz, M.F. Oliver, D. Waters, A. Zeiher, B.R. Chaitman, S. Leslie, and T. Stern Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial JAMA 285 2001 1711 1718
12. L.K. Newby, A. Kristinsson, M.V. Bhapkar, P.E. Aylward, A.P. Dimas, W.W. Klein, D.K. McGuire, D.J. Moliterno, F.W. Verheugt, W.D. Weaver, and R.M. Califf Early statin initiation and outcomes in patients with acute coronary syndromes JAMA 287 2002 3087 3095
13. S.E. Nissen Pathobiology, not angiography, should guide management in acute coronary syndrome/nonST-segment elevation myocardial infarction: the non-interventionist's perspective J Am Coll Cardiol 41 suppl 2003 103S 112S
14. E. Missel, G.S. Mintz, S.G. Carlier, K. Sano, J. Qian, R.K. Kaple, C. Castellanos, G. Dangas, R. Mehran, J.W. Moses, G.W. Stone, and M.B. Leon Necrotic core and its ratio to dense calcium are predictors of high-risk nonST-elevation acute coronary syndrome Am J Cardiol 101 2008 573 578
15. X. Wu, A. Maehara, G.S. Mintz, T. Kubo, K. Xu, S.Y. Choi, Y. He, N. Guo, J.W. Moses, M.B. Leon, B. De Bruyne, P.W. Serruys, and G.W. Stone Virtual histology intravascular ultrasound analysis of non-culprit attenuated plaques detected by grayscale intravascular ultrasound in patients with acute coronary syndromes Am J Cardiol 105 2010 48 53
16. S.H. Choi, A. Chae, E. Miller, M. Messig, F. Ntanios, A.N. DeMaria, S.E. Nissen, J.L. Witztum, and S. Tsimikas Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study J Am Coll Cardiol 52 2008 24 32
17. J.A. de Lemos, M.A. Blazing, S.D. Wiviott, E.F. Lewis, K.A. Fox, H.D. White, J.L. Rouleau, T.R. Pedersen, L.H. Gardner, R. Mukherjee, K.E. Ramsey, J. Palmisano, D.W. Bilheimer, M.A. Pfeffer, R.M. Califf, and E. Braunwald Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316
18. C.M. Gibson, Y.B. Pride, C.P. Hochberg, S. Sloan, M.S. Sabatine, and C.P. Cannon Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome PCI-PROVE IT: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection TherapyThrombolysis In Myocardial Infarction 22) substudy J Am Coll Cardiol 54 2009 2290 2295
19. T. Hiro, T. Kimura, T. Morimoto, K. Miyauchi, Y. Nakagawa, M. Yamagishi, Y. Ozaki, K. Kimura, S. Saito, T. Yamaguchi, H. Daida, and M. Matsuzaki Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study) J Am Coll Cardiol 54 2009 293 302
20. J. Qian, A. Maehara, G.S. Mintz, M.P. Margolis, S. Biro, G.W. Stone, and M.B. Leon Relation between individual plaque components and overall plaque burden in the prospective, multicenter virtual histology intravascular ultrasound registry Am J Cardiol 104 2009 501 506
21. S. Tsimikas, J.L. Witztum, E.R. Miller, W.J. Sasiela, M. Szarek, A.G. Olsson, and G.G. Schwartz High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial Circulation 110 2004 1406 1412
22. P.M. Ho, S.D. Fihn, L. Wang, C.L. Bryson, E. Lowy, C. Maynard, D.J. Magid, E.D. Peterson, R.L. Jesse, and J.S. Rumsfeld Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome Am Heart J 154 2007 846 851
23. M.L. Bilodeau, and D.I. Simon Clopidogrel for the hot patient Circ Cardiovasc Interv 2 2009 495 496
24. P. Tricoci, M.T. Roe, J. Mulgund, L.K. Newby, S.C. Smith Jr, C.V. Pollack Jr, D.J. Fintel, C.P. Cannon, D.L. Bhatt, W.B. Gibler, E.M. Ohman, E.D. Peterson, and R.A. Harrington Clopidogrel to treat patients with nonST-segment elevation acute coronary syndromes after hospital discharge Arch Intern Med 166 2006 806 811
25. A. Budaj, S. Yusuf, S.R. Mehta, K.A. Fox, G. Tognoni, F. Zhao, S. Chrolavicius, D. Hunt, M. Keltai, and M.G. Franzosi Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups Circulation 106 2002 1622 1626
26. B.S. Lewis, S.R. Mehta, K.A. Fox, D.A. Halon, F. Zhao, R.J. Peters, M. Keltai, A. Budaj, and S. Yusuf Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study Am Heart J 150 2005 1177 1784
27. P.W. Serruys, M.C. Morice, A.P. Kappetein, A. Colombo, D.R. Holmes, M.J. Mack, E. Stahle, T.E. Feldman, M. van den Brand, E.J. Bass, N. Van Dyck, K. Leadley, K.D. Dawkins, and F.W. Mohr Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
28. M.R. Movahed, J. John, M. Hashemzadeh, and M.M. Jamal Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States (19882004) based on race, gender, infarct location and comorbidities Am J Cardiol 104 2009 1030 1034